Nancy Risebrough

发表论文 64 篇 · 总被引 1047 次 · h-index 18

代表论文

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis (2022 · Advances in Therapy · 被引 45)
<p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p> (2019 · International Journal of COPD · 被引 36)
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK (2020 · ERJ Open Research · 被引 20)
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial (2022 · International Journal of COPD · 被引 19)
Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics (2021 · Clinical Therapeutics · 被引 12)
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial (2021 · Current Oncology · 被引 11)